Global Drug–Device Combination Products Market Research Report 2019

Table of Contents

Executive Summary

1 Drug–Device Combination Products Market Overview

• 1.1 Product Overview and Scope of Drug–Device Combination Products
• 1.2 Drug–Device Combination Products Segment by Type
  • 1.2.1 Global Drug–Device Combination Products Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Infusion Pumps
  • 1.2.3 Orthopedic Combination Products
  • 1.2.4 Photodynamic Therapy Devices
  • 1.2.5 Transdermal Patches
  • 1.2.6 Drug Eluting Stents
  • 1.2.7 Wound Care Products
  • 1.2.8 Inhalers
  • 1.2.9 Other
• 1.3 Drug–Device Combination Products Segment by Application
  • 1.3.1 Drug–Device Combination Products Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Global Drug–Device Combination Products Market by Region
  • 1.4.1 Global Drug–Device Combination Products Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Drug–Device Combination Products Market Size
  • 1.5.1 Global Drug–Device Combination Products Revenue (2014-2025)
  • 1.5.2 Global Drug–Device Combination Products Production (2014-2025)

2 Global Drug–Device Combination Products Market Competition by Manufacturers

• 2.1 Global Drug–Device Combination Products Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Drug–Device Combination Products Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Drug–Device Combination Products Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Drug–Device Combination Products Production Sites, Area Served, Product Types
• 2.5 Drug–Device Combination Products Market Competitive Situation and Trends
  • 2.5.1 Drug–Device Combination Products Market Concentration Rate
  • 2.5.2 Drug–Device Combination Products Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Drug–Device Combination Products Production Market Share by Regions

• 3.1 Global Drug–Device Combination Products Production Market Share by Regions
• 3.2 Global Drug–Device Combination Products Revenue Market Share by Regions (2014-2019)
• 3.3 Global Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Drug–Device Combination Products Production
  • 3.4.1 North America Drug–Device Combination Products Production Growth Rate (2014-2019)
  • 3.4.2 North America Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Drug–Device Combination Products Production
  • 3.5.1 Europe Drug–Device Combination Products Production Growth Rate (2014-2019)
  • 3.5.2 Europe Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Drug–Device Combination Products Production (2014-2019)
  • 3.6.1 China Drug–Device Combination Products Production Growth Rate (2014-2019)
  • 3.6.2 China Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Drug–Device Combination Products Production (2014-2019)
  • 3.7.1 Japan Drug–Device Combination Products Production Growth Rate (2014-2019)
  • 3.7.2 Japan Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Drug–Device Combination Products Consumption by Regions

• 4.1 Global Drug–Device Combination Products Consumption by Regions
• 4.2 North America Drug–Device Combination Products Consumption (2014-2019)
• 4.3 Europe Drug–Device Combination Products Consumption (2014-2019)
• 4.4 China Drug–Device Combination Products Consumption (2014-2019)
• 4.5 Japan Drug–Device Combination Products Consumption (2014-2019)

5 Global Drug–Device Combination Products Production, Revenue, Price Trend by Type

• 5.1 Global Drug–Device Combination Products Production Market Share by Type (2014-2019)
• 5.2 Global Drug–Device Combination Products Revenue Market Share by Type (2014-2019)
• 5.3 Global Drug–Device Combination Products Price by Type (2014-2019)
• 5.4 Global Drug–Device Combination Products Production Growth by Type (2014-2019)

6 Global Drug–Device Combination Products Market Analysis by Applications

• 6.1 Global Drug–Device Combination Products Consumption Market Share by Application (2014-2019)
• 6.2 Global Drug–Device Combination Products Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Drug–Device Combination Products Business

• 7.1 Abbott
  • 7.1.1 Abbott Drug–Device Combination Products Production Sites and Area Served
  • 7.1.2 Drug–Device Combination Products Product Introduction, Application and Specification
  • 7.1.3 Abbott Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Terumo Corporation
  • 7.2.1 Terumo Corporation Drug–Device Combination Products Production Sites and Area Served
  • 7.2.2 Drug–Device Combination Products Product Introduction, Application and Specification
  • 7.2.3 Terumo Corporation Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Stryker Corporation
  • 7.3.1 Stryker Corporation Drug–Device Combination Products Production Sites and Area Served
  • 7.3.2 Drug–Device Combination Products Product Introduction, Application and Specification
  • 7.3.3 Stryker Corporation Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Mylan
  • 7.4.1 Mylan Drug–Device Combination Products Production Sites and Area Served
  • 7.4.2 Drug–Device Combination Products Product Introduction, Application and Specification
  • 7.4.3 Mylan Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Medtronic
  • 7.5.1 Medtronic Drug–Device Combination Products Production Sites and Area Served
  • 7.5.2 Drug–Device Combination Products Product Introduction, Application and Specification
  • 7.5.3 Medtronic Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Allergan
  • 7.6.1 Allergan Drug–Device Combination Products Production Sites and Area Served
  • 7.6.2 Drug–Device Combination Products Product Introduction, Application and Specification
  • 7.6.3 Allergan Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Boston Scientific
  • 7.7.1 Boston Scientific Drug–Device Combination Products Production Sites and Area Served
  • 7.7.2 Drug–Device Combination Products Product Introduction, Application and Specification
  • 7.7.3 Boston Scientific Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Novartis
  • 7.8.1 Novartis Drug–Device Combination Products Production Sites and Area Served
  • 7.8.2 Drug–Device Combination Products Product Introduction, Application and Specification
  • 7.8.3 Novartis Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 C.R. Bard
  • 7.9.1 C.R. Bard Drug–Device Combination Products Production Sites and Area Served
  • 7.9.2 Drug–Device Combination Products Product Introduction, Application and Specification
  • 7.9.3 C.R. Bard Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Teleflex Incorporated
  • 7.10.1 Teleflex Incorporated Drug–Device Combination Products Production Sites and Area Served
  • 7.10.2 Drug–Device Combination Products Product Introduction, Application and Specification
  • 7.10.3 Teleflex Incorporated Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served

8 Drug–Device Combination Products Manufacturing Cost Analysis

• 8.1 Drug–Device Combination Products Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Drug–Device Combination Products
• 8.4 Drug–Device Combination Products Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Drug–Device Combination Products Distributors List
• 9.3 Drug–Device Combination Products Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Drug–Device Combination Products Market Forecast

• 11.1 Global Drug–Device Combination Products Production, Revenue Forecast
  • 11.1.1 Global Drug–Device Combination Products Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Drug–Device Combination Products Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Drug–Device Combination Products Price and Trend Forecast (2019-2025)
• 11.2 Global Drug–Device Combination Products Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Drug–Device Combination Products Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Drug–Device Combination Products Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Drug–Device Combination Products Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Drug–Device Combination Products Production, Revenue Forecast (2019-2025)
• 11.3 Global Drug–Device Combination Products Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Drug–Device Combination Products Consumption Forecast (2019-2025)
  • 11.3.2 Europe Drug–Device Combination Products Consumption Forecast (2019-2025)
  • 11.3.3 China Drug–Device Combination Products Consumption Forecast (2019-2025)
  • 11.3.4 Japan Drug–Device Combination Products Consumption Forecast (2019-2025)
• 11.4 Global Drug–Device Combination Products Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Drug–Device Combination Products Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List